(Q47418287)

16 January 2018

title

Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion (English)

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Cardiology and cardiovascular medicine

10 November 2022

main subject

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

10 November 2022

6

Virmani R

1 reference

16 January 2018

author name string

Pitarys CJ 2nd

2

1 reference

16 January 2018

M. B. Forman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729335

10 November 2022

C. J. Pitarys

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729335

10 November 2022

H. D. Vildibill

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729335

10 November 2022

T. L. Lambert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729335

10 November 2022

D. A. Ingram

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729335

10 November 2022

J. J. Murray

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729335

10 November 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

16 January 2018

full work available at URL

https://api.elsevier.com/content/article/PII:073510979290074W?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

https://api.elsevier.com/content/article/PII:073510979290074W?httpAccept=text/plain

10 November 2022

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Journal of the American College of Cardiology

10 November 2022

published in

1 reference

16 January 2018

volume

19

1 reference

16 January 2018

issue

1

1 reference

16 January 2018

page(s)

205-216

1 reference

16 January 2018

Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion

cites work

5

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Myocardial reperfusion: a double-edged sword?

10 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Endothelial and myocardial injury during ischemia and reperfusion: pathogenesis and therapeutic implications

10 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation

10 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Clinical use of a blood substitute

10 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Failure of the xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs

10 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion

10 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Animal models for protecting ischemic myocardium: results of the NHLBI Cooperative Study. Comparison of unconscious and conscious dog models.

10 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

The loss of radioactive microspheres from canine necrotic myocardium

10 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period.

10 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Perfluorochemical blood substitutes differentially alter human monocyte procoagulant generation and oxidative metabolism.

10 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart

10 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion

10 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

10 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extra myocardial mechanism of ischemic injury

10 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury

10 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function

10 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog

10 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Reduction by Cobra Venom Factor of Myocardial Necrosis after Coronary Artery Occlusion

10 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Demonstration of myocardial reperfusion injury in humans: results of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction

10 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine reperfusion model

10 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Effects of potential blood substitutes (perfluorochemicals) on rat liver and spleen

10 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA

10 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol

10 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90074-W

10 November 2022

Identifiers

1 reference

16 January 2018

1 reference

16 January 2018